Sujal was Director, Healthcare Investment Banking for Citigroup. Sujal Shah joined CymaBay Therapeutics in 2013. Sujal served as Chief Financial Officer and Interim Chief Executive Officer for CymaBay Therapeutics.
Sujal Shah is currently
Create your alert
to follow the career of Sujal Shah.
Sujal Shah has a Master of Science in Biomedical Engineering from Northwestern University in 1997 and a Master of Business Administration in Finance and Accounting from Carnegie Mellon University - Tepper School of Business in 2004.
They have also studied at Northwestern University :
Find more alumni from Northwestern University
They have also studied at Carnegie Mellon University - Tepper School of Business :
Find more alumni from Carnegie Mellon University - Tepper School of Business
Do you need to know more about Sujal Shah? More results.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.